ReviewFrontiers in pharmacology2026

Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome-drug-host triad.

David Strilić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.